| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | B02 | CTRPv2 | pan-cancer | AAC | -0.08 | 0.02 |
| mRNA | Rapamycin | gCSI | pan-cancer | AAC | -0.12 | 0.02 |
| mRNA | XMD14-99 | GDSC1000 | pan-cancer | AAC | -0.072 | 0.02 |
| mRNA | BRD-K16147474 | CTRPv2 | pan-cancer | AAC | 0.086 | 0.02 |
| mRNA | decitabine | CTRPv2 | pan-cancer | AAC | 0.059 | 0.03 |
| mRNA | Cytarabine | GDSC1000 | pan-cancer | AAC | -0.076 | 0.03 |
| mRNA | paclitaxel | CTRPv2 | pan-cancer | AAC | -0.071 | 0.03 |
| mRNA | Oxaliplatin | CTRPv2 | pan-cancer | AAC | -0.07 | 0.03 |
| mRNA | PD-0325901 | gCSI | pan-cancer | AAC | -0.11 | 0.03 |
| mRNA | Talazoparib | GDSC1000 | pan-cancer | AAC | -0.071 | 0.03 |